Bedaquiline, pretomanid, and linezolid with or without moxifloxacin for tuberculosis.

Saved in:
Bibliographic Details
Title: Bedaquiline, pretomanid, and linezolid with or without moxifloxacin for tuberculosis.
Authors: Labuda SM; US Centers for Disease Control and Prevention, Division of Tuberculosis Elimination, Atlanta, GA 30329, USA., Seaworth B; Heartland National Tuberculosis Center, San Antonio, TX, USA., Dasgupta S; Los Angeles County Department of Public Health, Los Angeles, CA, USA., Goswami ND; US Centers for Disease Control and Prevention, Division of Tuberculosis Elimination, Atlanta, GA 30329, USA. Electronic address: nef7@cdc.gov.
Corporate Authors: BPaL Accelerated Monitoring Project Team
Source: The Lancet. Respiratory medicine [Lancet Respir Med] 2024 Feb; Vol. 12 (2), pp. e5-e6. Date of Electronic Publication: 2023 Nov 30.
Publication Type: Letter
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101605555 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-2619 (Electronic) Linking ISSN: 22132600 NLM ISO Abbreviation: Lancet Respir Med Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38043563
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Bedaquiline, pretomanid, and linezolid with or without moxifloxacin for tuberculosis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Labuda+SM%22">Labuda SM</searchLink>; US Centers for Disease Control and Prevention, Division of Tuberculosis Elimination, Atlanta, GA 30329, USA.<br /><searchLink fieldCode="AU" term="%22Seaworth+B%22">Seaworth B</searchLink>; Heartland National Tuberculosis Center, San Antonio, TX, USA.<br /><searchLink fieldCode="AU" term="%22Dasgupta+S%22">Dasgupta S</searchLink>; Los Angeles County Department of Public Health, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Goswami+ND%22">Goswami ND</searchLink>; US Centers for Disease Control and Prevention, Division of Tuberculosis Elimination, Atlanta, GA 30329, USA. Electronic address: nef7@cdc.gov.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22BPaL+Accelerated+Monitoring+Project+Team%22">BPaL Accelerated Monitoring Project Team</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101605555%22">The Lancet. Respiratory medicine</searchLink> [Lancet Respir Med] 2024 Feb; Vol. 12 (2), pp. e5-e6. <i>Date of Electronic Publication: </i>2023 Nov 30.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101605555 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2213-2619 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2222132600%22">22132600 </searchLink><i>NLM ISO Abbreviation: </i>Lancet Respir Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38043563
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/S2213-2600(23)00426-5
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e5
    Titles:
      – TitleFull: Bedaquiline, pretomanid, and linezolid with or without moxifloxacin for tuberculosis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Labuda SM
      – PersonEntity:
          Name:
            NameFull: Seaworth B
      – PersonEntity:
          Name:
            NameFull: Dasgupta S
      – PersonEntity:
          Name:
            NameFull: Goswami ND
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2024 Feb
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2213-2619
          Numbering:
            – Type: volume
              Value: 12
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: The Lancet. Respiratory medicine
              Type: main
ResultId 1